Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 8,300 shares at $582.86 ($4.9M) on 2026-05-07, disclosed to the SEC on 2026-05-07.
Scheduled sale ($4.9M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $582.86 | 80 | $47K | 1.0% |
| 2 | $584.07 | 1,475 | $862K | 17.7% |
| 3 | $585.18 | 994 | $582K | 11.9% |
| 4 | $586.17 | 1,689 | $990K | 20.3% |
| 5 | $587.61 | 2,970 | $1.7M | 35.8% |
| 6 | $588.51 | 820 |
| $483K |
| 9.9% |
| 7 | $596.19 | 70 | $42K | 0.9% |
| 8 | $597.54 | 202 | $121K | 2.5% |
| Total | $586.75 avg | 8,300 | $4.9M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-18 | $4.1M | — | Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |